Trial NCT02348203

Aspirin and Zileuton and Biomarker Expression in Nasal Tissue of Current Smokers

This randomized phase II trial studies the effects of aspirin and zileuton on genes related
to tobacco use in current smokers. Aspirin and zileuton may interfere with genes related to
tobacco use and may be useful in preventing lung cancer in current smokers.


Aspirin, Laboratory Biomarker Analysis, Placebo Administration, Zileuton


Tobacco Use Disorder


Linda L Garland

See list of participating sites